Jasper Therapeutics, Inc.
NASDAQ:JSPR
2.72 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 71.637 | 86.887 | 38.25 | 84.701 | 19.838 | 27.163 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 100.155 |
| Cash and Short Term Investments
| 71.637 | 86.887 | 38.25 | 84.701 | 19.838 | 100.155 |
| Net Receivables
| 0 | 0.25 | 1.159 | 0.698 | 0.6 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.174 | 1.801 | 2.322 | 2.432 | 0.247 | -72.992 |
| Total Current Assets
| 75.811 | 88.938 | 41.731 | 87.831 | 20.685 | 27.163 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 2.851 | 4.194 | 5.454 | 4.833 | 2.029 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | -0.98 | -0.668 | -0.744 | 0 |
| Long Term Investments
| 0.417 | 0.417 | 0.417 | 0.345 | 0.345 | 0 |
| Tax Assets
| 0 | 0 | 0.563 | 0.323 | 0.399 | 0 |
| Other Non-Current Assets
| 0.82 | 1.343 | 1.176 | 0.99 | 0.643 | 0.048 |
| Total Non-Current Assets
| 4.088 | 5.954 | 6.63 | 5.823 | 2.672 | 0.048 |
| Total Assets
| 79.899 | 94.892 | 48.361 | 93.654 | 23.357 | 27.211 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 4.027 | 4.149 | 1.768 | 3.919 | 1.417 | 0.623 |
| Short Term Debt
| 1.089 | 0.972 | 1.73 | 1.01 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0.005 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 10.121 | 7.253 | 3.567 | 3.091 | 2.59 | 1.37 |
| Total Current Liabilities
| 15.237 | 12.374 | 7.065 | 8.02 | 4.012 | 1.993 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0.724 | 1.814 | 2.786 | 2.38 | 1.624 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | -0.563 | -0.323 | -0.399 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0.563 | 0.323 | 0.399 | 0 |
| Other Non-Current Liabilities
| 2.264 | 2.264 | 2.521 | 13.736 | 52.851 | 0 |
| Total Non-Current Liabilities
| 2.988 | 4.078 | 5.307 | 16.116 | 54.475 | 0 |
| Total Liabilities
| 18.225 | 16.452 | 12.372 | 24.136 | 58.487 | 1.993 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 48.361 | 93.654 | 43.84 | 25.836 |
| Common Stock
| 0.002 | 0.001 | 0.004 | 0.004 | 0.001 | 0.01 |
| Retained Earnings
| -240.869 | -169.6 | -105.135 | -67.45 | -36.813 | -5.144 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -93.654 | 0 | 0 |
| Other Total Stockholders Equity
| 302.541 | 248.039 | 141.12 | 136.964 | 1.682 | 0.4 |
| Total Shareholders Equity
| 61.674 | 78.44 | 35.989 | 69.518 | 8.71 | 21.102 |
| Total Equity
| 61.674 | 78.44 | 35.989 | 69.518 | -35.13 | 21.102 |
| Total Liabilities & Shareholders Equity
| 79.899 | 94.892 | 48.361 | 93.654 | 23.357 | 23.095 |